<DOC>
	<DOCNO>NCT01614418</DOCNO>
	<brief_summary>Gastric intestinal metaplasia ( IM ) dysplasia , also refer intra-epithelial neoplasia , well recognize precursor gastric cancer . Apart endoscopic surveillance , intervention predictably eradicate pre-cancerous gastric lesion . Endoscopic radiofrequency ablative ( RFA ) therapy recently show highly effective eradicate IM dysplasia patient Barrett 's esophagus . However , potential role RFA remove gastric IM dysplasia remain unknown . In study , determine feasibility use endoscopic RFA treat early gastric neoplasia ( metaplasia dysplasia ) . Patients gastric metaplasia and/or dysplasia treat endoscopic RFA . The safety effect RFA determine .</brief_summary>
	<brief_title>Radiofrequency Ablation Gastric Metaplasia Dysplasia</brief_title>
	<detailed_description />
	<mesh_term>Metaplasia</mesh_term>
	<criteria>1 . Histological confirmation gastric IM dysplasia . 2 . The lesion large 5 cm diameter . 3 . Age â‰¥ 18 year . 4 . No previous endoscopic mucosal resection submucosal dissection . 5 . No active H. pylorus infection . 6 . Subject able tolerate endoscopy sedation . 7 . Subject agree participate , fully understand content informed consent , sign inform consent form . 1 . Gastric cancer ( intramucosal cancer worse ) . 2 . Prior gastric irradiation surgery . 3 . Antiplatelet antithrombotic medication use stop 7 day RFA . 4 . Gastric ulcer , fistulae varix . 5 . History alcohol and/or control substance dependency . 6 . Pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>